PT Charlie Hospital Semarang Tbk
IIDX:RSCH610.00
IDR
+30.00
(+5.17%)
ISIN
ID1000197304
Return %
Stock
S&P 500
1Y
54.82
14.20
3Y
408.33
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- H. Junianto
- Full Time Employees
- 214
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Semarang Indonesia
- IPO Date
- Aug 28, 2023
- Website
- charliehospital.co.id
- Similar Companies
- Business
- PT Charlie Hospital Semarang Tbk is an Indonesia-based healthcare services provider primarily engaged in the ownership, operation, and management of private general hospitals and specialized healthcare facilities. Founded in 2019 and headquartered in Kendal Regency, Central Java, Indonesia, the company operates within the Wahyu Agung Group corporate network and serves public and private patients throughout the Central Java region. The company provides a comprehensive suite of medical, diagnostic, and clinical care services, organized systematically into primary offerings including 24-hour emergency and trauma care (IGD); inpatient accommodation across various ward and private room classifications; outpatient polyclinic consultations across multiple medical specialties, including internal medicine, obstetrics and gynecology, pediatrics, general surgery, orthopedics, neurology, cardiology, pulmonology, and dentistry; central operating theater and surgical installations; critical care monitoring through intensive care units (ICU), high care units (HCU), and neonatal and perinatal care units; clinical pathology and diagnostic laboratory testing; medical imaging and radiology services, including digital X-ray and panoramic imaging; 24-hour in-house pharmacy and pharmaceutical dispensing; physical therapy and medical rehabilitation; speech therapy; clinical nutrition and dietary management; routine medical check-ups and preventative wellness center programs; and dedicated ambulance patient transport services. In addition to core hospital operations, the company maintains secondary business segments in building construction services and building materials trading. In recent corporate developments, the company listed its shares on the Indonesia Stock Exchange under the ticker symbol RSCH following an initial public offering in August 2023, raising IDR 60.95 billion to accelerate network expansion. In September 2024, the company commercially opened its second healthcare facility, Charlie Hospital Demak, establishing a six-story, 178-bed Class C hospital spanning 17,672 square meters in Demak Regency. In February 2025, the company strengthened its financial structure by securing a credit facility of IDR 150 billion from PT Bank Mandiri (Persero) Tbk, comprising an IDR 140 billion investment credit for healthcare infrastructure development and an IDR 10 billion invoice financing facility backed by healthcare receivables. In May 2025, the company expanded its patient volume and community reach by signing a strategic healthcare cooperation agreement with national social security administrator BPJS Kesehatan for the Demak hospital, effective June 2025, integrating the facility into the national health insurance network across emergency, outpatient, and inpatient referral services.